Daily Archives: January 14, 2013
Neuralstem Receives FDA Approval To Commence Spinal Cord Injury Trial
NSI-566 to be tested in patients with chronic spinal cord injury
ROCKVILLE, Md., Jan. 14, 2013 /PRNewswire/ --Â Neuralstem, Inc. (NYSE MKT: CUR) announced that it...